Company Announcements

Cellix named Crisel Instruments as an Italian distributor and Chromaphor Analysen-Tecknik as a German distributor.

GE Healthcare named Stephen Minger, PhD, as head of R&D for Cell Technologies in September. He was previously senior lecturer and director of King’s College London’s Stem Cell Biology Laboratory.

In October, Enzo Biochem Life Sciences announced a comarketing partnership with BioTek Instruments for the study of live cells.

CYTOO SA closed a $4.7 million second funding round in September, led by Auriga Partners, a new investor.

In October, Cyntellect established European operations with the opening of a UK-based office.

According to a filing with the SEC, Cyntellect raised $15.5 million through an issue of securities and warrants.

LI-COR Biosciences agreed to distribute in the US Chemometec A/S’s NucleoCounter NC-100 for the automated counting of mammalian cells.

Glencoe Software, the commercial arm of the Open Microscopy Environment, announced a collaboration with the American Society of Cell Biology’s “The Cell: An Image Library” project to build a multidimensional image library of the cell.

Product Introductions

IonGate Biosciences GmbH introduced the SURFE2R (Surface Electrogenic Event Reader) Workstation 5, a semi-automated, benchtop system for electrically-active transporters.

PROdesign GmbH launched the PROcellcare cell-feeding system based on a 96-well plate for automated cell culturing, exchange of nutrient and working solutions, image and video analyses of basic work, and long-term tests.

PerkinElmer released the web-enabled Columbus 2.0 platform, its flagship high-content screening data management software for cellular imaging and analysis.

Cyntellect introduced the Celigo adherent cell cytometry system for noninvasive in situ live cell imaging, featuring both brightfield and multicolor fluorescence modules.

Applied BioPhysics introduced the ECIS Z theta 96-well system for measuring barrier function of cell monolayers in culture.

Fluxion Biosciences launched a new microplate for its BioFlux live cell imaging workstation, extending its shear flow limits to simulate a variety of pathological vascular conditions.

Sales/Orders of Note

Fluxion Biosciences received a $1.8 million National Institutes of Health grant for the development of a screening platform for anti-microbial drug discovery.